Small Particles, Big Impact: Inorganic Nanotechnology for Glioblastoma
Despite promising preclinical results, clinical translation requires careful optimization of nanoparticle properties to minimize toxicity and immune clearance. Understanding these challenges provides a roadmap for the development of more effective nanomedicine strategies aimed at improving outcomes for GBM patients.
Authors
- Klaudia Dynarowicz (ORCID: https://orcid.org/0000-0001-6851-5869)
- Aleksandra KAWCZYK-KRUPKA
- Jakub Tylutki
- Dorota Bartusik-Aebisher
- Nazarii Kozak
Institutions
- Medical University of Silesia (PL)
- Science Club (US)
- University of Rzeszów (PL)
Publication Details
- Journal
- Molecules
- Published
- 2026-02-06
- DOI
- https://doi.org/10.3390/molecules31030565
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00